These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 34370)

  • 1. Long-term suppression of pain by narcotic drugs in the absence of tolerance development.
    Colpaert FC
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):293-5. PubMed ID: 34370
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comprehensive study of the neurochemical and immune mechanisms of morphine tolerance: the effects of naloxone].
    Litvinova SV; Shul'govskiĭ VV; Gruden' MA; Panchenko LF; Terebilina NN; Aristova VV; Kaliuzhnyĭ AL
    Patol Fiziol Eksp Ter; 2000; (1):6-9. PubMed ID: 10741178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can chronic pain be suppressed despite purported tolerance to narcotic analgesia?
    Colpaert FC
    Life Sci; 1979 Mar; 24(13):1201-9. PubMed ID: 36539
    [No Abstract]   [Full Text] [Related]  

  • 5. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of prior fentanyl administration and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia.
    Colpaert FC; Niemegeers CJ; Janssen PA; Maroli AN
    J Pharmacol Exp Ther; 1980 May; 213(2):418-24. PubMed ID: 6102603
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the alteration of analgesic receptor-antagonist interaction induced by morphine.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):401-7. PubMed ID: 4153360
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ritanserin prolongs the analgesic effect of morphine and slows the development of tolerance].
    Verbitskaia EV; Kudriashova MF
    Eksp Klin Farmakol; 1997; 60(2):10-3. PubMed ID: 9206558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
    Yano I; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the discriminative effects of morphine in the rat.
    Shannon HE; Holtzman SG
    J Pharmacol Exp Ther; 1976 Jul; 198(1):54-65. PubMed ID: 6794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin attenuates the development and expression of tolerance to morphine-induced antinociception in mice.
    Chavooshi B; Saberi M; Pournaghash Tehrani S; Bakhtiarian A; Ahmadiani A; Haghparast A
    Pharmacol Biochem Behav; 2009 Aug; 93(2):155-9. PubMed ID: 19446576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy II: narcotic and narcotic-antagonists analgesics.
    Gardier RW
    Dent Clin North Am; 1978 Jan; 22(1):125-41. PubMed ID: 23324
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
    Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine withdrawal modifies antinociceptive effects of acute morphine in rats.
    Dong Z; Mao R; Han H; Cao J; Xu L
    Biochem Biophys Res Commun; 2006 Jul; 346(2):578-82. PubMed ID: 16762316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
    Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
    Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast.
    Lilius TO; Rauhala PV; Kambur O; Kalso EA
    Anesthesiology; 2009 Dec; 111(6):1356-64. PubMed ID: 19934882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.